Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

NCT03137992 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

377

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Placebo
DRUG: Test Product (tiotropium bromide inhalation powder)
DRUG: Reference Product (Spiriva®)

Sponsor

Lupin, Inc.